TNF Pharma - TNFA Market Capitalization

TNF Pharmaceuticals (TNFA) relies on patent protection for its anti-inflammatory formulas to overcome the challenges of costly development and legal risks. Current capitalization stands at 0.01, while the price visualization available on the GURU.Markets page accompanies an analysis of the high-cost metabolic pathology pipeline. The company's growth is based on partnerships with biotech centers, which enhances its attractiveness for potential mergers.

TNF Pharmaceuticals Inc. - TNFA Market Capitalization (period 07/25/2024 - 09/25/2025)

Comprehensive metric breakdowns and analytics for tnfpharma.com (TNFA)

- market price and analyst price targets:

Price Chart TNF Pharmaceuticals, Inc.|TNFA - Broker Consensus Forecast

- issuer market value details:

Market Capitalization TNF Pharmaceuticals, Inc.|TNFA - Full Business Value

- issuer book value statistics:

Book Value per Share TNF Pharmaceuticals|TNFA - Book Capitalization|Market Value to Book Value Ratio tnfpharma.com|TNFA - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital TNF Pharmaceuticals|TNFA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital TNF Pharmaceuticals, Inc.|TNFA - Company Aggregate Debts|Debt to Book Capitalization Ratio TNF Pharmaceuticals, Inc.|TNFA - Company Long-Term Loans and Borrowings|Company Short-Term Debt TNF Pharmaceuticals|Quick Ratio tnfpharma.com

- financial results and valuation multiples details:

TNFA - Net Profit|Future Profit TNF Pharmaceuticals|TNFA - Company Value to Net Income|Future Price to Earnings TNF Pharmaceuticals, Inc.|TNFA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio TNF Pharmaceuticals, Inc.|TNFA - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) TNF Pharmaceuticals|TNFA - Earnings per share for the trailing year|Quarterly EPS earnings growth tnfpharma.com|TNFA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year TNF Pharmaceuticals

- total revenue and sales volume data:

TNFA - Company Sales Revenue|Company Future Sales Volume TNF Pharmaceuticals, Inc.|TNFA - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio TNF Pharmaceuticals, Inc.

Fundamental company analysis:TNFA (TNF Pharma)

Professional asset selection begins with an analysis of market value to assess business resilience. This indicator aggregates all outstanding shares at the current price, defining 0.01 as the final scale of capital. By analyzing the company's market value, an investor separates speculative noise from actual capitalization. For TNF Pharmaceuticals (TNFA), this metric reflects market confidence in clinical trials. The issuer's stable balance sheet confirms the validity of the current valuation.

Key competitors